[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Novel Vaccine Delivery System Market Size study, by Delivery Mode (intradermal, subcutaneous, intramuscular, and other), by Device (Syringe, Needle-Free, Injection System and other) and Regional Forecasts 2021-2027

July 2021 | 200 pages | ID: GF2241E66D28EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Novel Vaccine Delivery System Market is valued at approximately USD XX Billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Vaccines generally consist of a disease-causing germ-like agent, produced through inactive or weakened microorganisms, their toxins, or one of the surface proteins. Through these agents, the immune system recognizes the agent as threat, providing antibodies to protect the body from real or active or stronger germ that may harm the body. Vaccines are provided to different age groups to strengthen their immune system, keeping them safe from certain kinds of infections and diseases throughout the life. Novel Vaccine Delivery comprises of formulations, technologies, methods, and systems to transfer an active pharmaceuticals ingredient in the body, as required, to safely complete its therapeutic effect. Growing immunization programs and their increasing coverage is expected to fuel the Novel Vaccine Delivery System Market. Increasing government support and investment is also propelling the market growth. . For instance, in August 2020, Hindustan Syringes & Medical Devices Ltd. (HMD) announced that it has received an order of 140 million auto disabled syringes for COVID-19 from the Unites Nations Children’s Fund (UNICEF). Moreover, several key players are taking strategic initiatives to expand their presence in the market for instance
• In July, 2020, Retractable technologies entered into Technology Investment Agreement (TIA) , that is of USD 53.6 million with the United States government, aiming to expand its domestic production of needles and syringes.

However, high cost and unaffordability of safety syringes may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Novel Vaccine Delivery System Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). Asia-Pacific is expected to be the fastest growing market in the forecast period, due to constantly expanding healthcare infrastructure, economic development, are expected to drive the market growth of Novel Vaccine Delivery system market in emerging countries of the region. Also, Asia-Pacific is the most highly populated region across the globe, and increasing population estimates increase in vaccine consumption over time, ultimately boosting novel vaccine delivery market. Supporting the drivers, according to UNICEF India 2020, over 9 million immunization sessions were held across India every year aiming full immunization coverage. The program introduced new vaccines, including the Pneumococcal Conjugate Vaccine (PVC) and Rotavirus Vaccine (RVV).




Major market player included in this report are:

Altaris Capital Partners, LLC
Becton, Dickinson and Company
Carl Zeiss Foundation
Gerresheimer AG
Gurnet Point Capital
Inovio Pharmaceuticals Inc.
Pharmajet Inc.
Retractable Technologies Inc.,
Terumo Corporation
VAXXAS Pty Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Delivery Mode:
Intradermal
Subcutaneous
Intramuscular
Other

By Device:
Syringe
Needle-Free
Injection System
Other

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018-19
Base year – 2019-2020
Forecast period – 2021 to 2027.

Target Audience of the Global Novel Vaccine Delivery System Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
  1.2.1. Novel Vaccine Delivery Market, by Delivery Mode, 2019-2027 (USD Billion)
  1.2.2. Novel Vaccine Delivery Market, by Device, 2019-2027 (USD Billion)
  1.2.3. Novel Vaccine Delivery Market by Region, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL NOVEL VACCINE DELIVERY MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL NOVEL VACCINE DELIVERY MARKET DYNAMICS

3.1. Novel Vaccine Delivery Market Impact Analysis (2019-2027)
  3.1.1. Market Drivers
    3.1.1.1. Growing immunization programs and their increasing coverage
    3.1.1.2. Increasing government support and investment
    3.1.1.3. Development of novel vaccines
  3.1.2. Market Restraint
    3.1.2.1. High cost and unaffordability of safety and syringes
    3.1.2.2. Alternative modes of drugs delivery
  3.1.3. Market Opportunities
    3.1.3.1. Rise in need for safety syringes in emerging economies
    3.1.3.2. FDA approval to COVID 19 vaccine

CHAPTER 4. GLOBAL NOVEL VACCINE DELIVERY MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL NOVEL VACCINE DELIVERY MARKET, BY DEVICE

5.1. Market Snapshot
5.2. Global Novel Vaccine Delivery Market by Device, Performance - Potential Analysis
5.3. Global Novel Vaccine Delivery Market Estimates & Forecasts by Device 2018-2027 (USD Billion)
5.4. Novel Vaccine Delivery Market, Sub Segment Analysis
  5.4.1. Syringe
  5.4.2. Needle-Free
  5.4.3. Injection System
  5.4.4. Other

CHAPTER 6. GLOBAL NOVEL VACCINE DELIVERY MARKET, BY DELIVERY MODE

6.1. Market Snapshot
6.2. Global Novel Vaccine Delivery Market by packaging, Delivery Mode - Potential Analysis
6.3. Global Novel Vaccine Delivery Market Estimates & Forecasts by delivery mode 2018-2027 (USD Billion)
6.4. Novel Vaccine Delivery Market, Sub Segment Analysis
  6.4.1. Intradermal
  6.4.2. Subcutaneous
  6.4.3. Intramuscular
  6.4.4. Other

CHAPTER 7. GLOBAL NOVEL VACCINE DELIVERY MARKET, REGIONAL ANALYSIS

7.1. Novel Vaccine Delivery Market, Regional Market Snapshot
7.2. North America Novel Vaccine Delivery Market
  7.2.1. U.S. Novel Vaccine Delivery Market
    7.2.1.1. Type breakdown estimates & forecasts, 2018-2027
    7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
    7.2.1.3. End use breakdown estimates & forecasts, 2018-2027
  7.2.2. Canada Novel Vaccine Delivery Market
7.3. Europe Novel Vaccine Delivery Market Snapshot
  7.3.1. U.K. Novel Vaccine Delivery Market
  7.3.2. Germany Novel Vaccine Delivery Market
  7.3.3. France Novel Vaccine Delivery Market
  7.3.4. Spain Novel Vaccine Delivery Market
  7.3.5. Italy Novel Vaccine Delivery Market
  7.3.6. Rest of Europe Novel Vaccine Delivery Market
7.4. Asia-Pacific Novel Vaccine Delivery Market Snapshot
  7.4.1. China Novel Vaccine Delivery Market
  7.4.2. India Novel Vaccine Delivery Market
  7.4.3. Japan Novel Vaccine Delivery Market
  7.4.4. Australia Novel Vaccine Delivery Market
  7.4.5. South Korea Novel Vaccine Delivery Market
  7.4.6. Rest of Asia Pacific Novel Vaccine Delivery Market
7.5. Latin America Novel Vaccine Delivery Market Snapshot
  7.5.1. Brazil Novel Vaccine Delivery Market
  7.5.2. Mexico Novel Vaccine Delivery Market
7.6. Rest of The World Novel Vaccine Delivery Market

CHAPTER 8. COMPETITIVE INTELLIGENCE

8.1. Top Market Strategies
8.2. Company Profiles
  8.2.1. Altariz Capital Partners LLC
    8.2.1.1. Key Information
    8.2.1.2. Overview
    8.2.1.3. Financial (Subject to Data Availability)
    8.2.1.4. Product Summary
    8.2.1.5. Recent Developments
  8.2.2. Becton, Dickinson and Company
  8.2.3. Carl Zeiss Foundation
  8.2.4. Gerresheimer AG
  8.2.5. Gurnet Point Capital
  8.2.6. Inovio Pharmaceuticals Inc.
  8.2.7. Pharmajet Inc.
  8.2.8. Retractable Technologies Inc.,
  8.2.9. Terumo Corporation
  8.2.10. VAXXAS Pty Ltd

CHAPTER 9. RESEARCH APPLICATION

9.1. Research Application
  9.1.1. Data Mining
  9.1.2. Analysis
  9.1.3. Market Estimation
  9.1.4. Validation
  9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES

TABLE 1. Global Novel Vaccine Delivery Market, report scope
TABLE 2. Global Novel Vaccine Delivery Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Novel Vaccine Delivery Market estimates & forecasts by devices 2018-2027 (USD Billion)
TABLE 4. Global Novel Vaccine Delivery Market estimates & forecasts by delivery mode 2018-2027 (USD Billion)
TABLE 5. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Novel Vaccine Delivery Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Novel Vaccine Delivery Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. U.S. Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Canada Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Canada Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. UK Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. UK Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. Germany Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. Germany Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. France Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. France Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Spain Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Spain Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Italy Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. Italy Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. ROE Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. ROE Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. China Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. China Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. India Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. India Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Japan Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Japan Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Australia Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 55. Australia Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. South Korea Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 58. South Korea Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. ROPAC Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 61. ROPAC Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. Brazil Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 64. Brazil Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Mexico Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 67. Mexico Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. ROLA Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 70. ROLA Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROW Novel Vaccine Delivery Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 73. ROW Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Novel Vaccine Delivery Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. List of secondary sources used in the study of global Novel Vaccine Delivery Market.
TABLE 76. List of primary sources used in the study of global Novel Vaccine Delivery Market.
TABLE 77. Years considered for the study.
TABLE 78. Exchange rates considered.
LIST OF FIGURES

FIG 1. Global Novel Vaccine Delivery Market, research methodology
FIG 2. Global Novel Vaccine Delivery Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Novel Vaccine Delivery Market, key trends 2019
FIG 5. Global Novel Vaccine Delivery Market, growth prospects 2020-2027
FIG 6. Global Novel Vaccine Delivery Market, porters 5 force model
FIG 7. Global Novel Vaccine Delivery Market, pest analysis
FIG 8. Global Novel Vaccine Delivery Market, value chain analysis
FIG 9. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Novel Vaccine Delivery Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Novel Vaccine Delivery Market, regional snapshot 2018 & 2027
FIG 18. North America Novel Vaccine Delivery Market 2018 & 2027 (USD Billion)
FIG 19. Europe Novel Vaccine Delivery Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Novel Vaccine Delivery Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Novel Vaccine Delivery Market 2018 & 2027 (USD Billion)
FIG 22. Global Novel Vaccine Delivery Market, company market share analysis (2019)


More Publications